390. Neuromod: How non-invasive ultrasound neuromodulation could change autoimmune disease treatment with Nishant Doctor of Surf Therapeutics by State of Medtech (opens in new tab)
Omar Khateeb speaks with Nishant Doctor, Founder, CEO, and CTO of Surf Therapeutics, about the next frontier of neurotechnology: using ultrasound neuromodulation to target inflammation.Nishant breaks down the science behind the cholinergic anti-inflammatory pathway, why the splenic nerve may offer a more direct target than the vagus nerve, and how non-invasive stimulation could create a different treatment path for rheumatoid arthritis patients.The episode also covers capital efficiency, firs...
Read the original article